126 related articles for article (PubMed ID: 7645971)
1. Analysis of ras gene mutations in hepatocellular carcinoma in southern African blacks.
Leon M; Kew MC
Anticancer Res; 1995; 15(3):859-61. PubMed ID: 7645971
[TBL] [Abstract][Full Text] [Related]
2. A rare point mutation in the Ras oncogene in hepatocellular carcinoma.
Taketomi A; Shirabe K; Muto J; Yoshiya S; Motomura T; Mano Y; Ikegami T; Yoshizumi T; Sugio K; Maehara Y
Surg Today; 2013 Mar; 43(3):289-92. PubMed ID: 23266750
[TBL] [Abstract][Full Text] [Related]
3. Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas.
Challen C; Guo K; Collier JD; Cavanagh D; Bassendine MF
J Hepatol; 1992 Mar; 14(2-3):342-6. PubMed ID: 1323601
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity in chromosome 4q12-q13 in hepatocellular carcinoma in southern African blacks.
Leon M; Kew MC
Anticancer Res; 1996; 16(1):349-51. PubMed ID: 8615634
[TBL] [Abstract][Full Text] [Related]
5. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
Cerutti P; Hussain P; Pourzand C; Aguilar F
Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
[TBL] [Abstract][Full Text] [Related]
6. Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing.
Tada M; Omata M; Ohto M
Cancer Res; 1990 Feb; 50(4):1121-4. PubMed ID: 2153451
[TBL] [Abstract][Full Text] [Related]
7. Ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chloride.
Devereux TR; Foley JF; Maronpot RR; Kari F; Anderson MW
Carcinogenesis; 1993 May; 14(5):795-801. PubMed ID: 8504471
[TBL] [Abstract][Full Text] [Related]
8. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
[TBL] [Abstract][Full Text] [Related]
9. Multiplex polymerase chain reaction amplification and direct sequencing of homologous sequences: point mutation analysis of the ras genes.
Manam S; Nichols WW
Anal Biochem; 1991 Nov; 199(1):106-11. PubMed ID: 1807152
[TBL] [Abstract][Full Text] [Related]
10. Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma.
Tsuda H; Hirohashi S; Shimosato Y; Ino Y; Yoshida T; Terada M
Jpn J Cancer Res; 1989 Mar; 80(3):196-9. PubMed ID: 2542205
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus precore mutants in serum and liver of Southern African Blacks with hepatocellular carcinoma.
Kramvis A; Kew MC; Bukofzer S
J Hepatol; 1998 Jan; 28(1):132-41. PubMed ID: 9537850
[TBL] [Abstract][Full Text] [Related]
12. H-ras oncogene point mutations in arthritic synovium.
Roivainen A; Jalava J; Pirilä L; Yli-Jama T; Tiusanen H; Toivanen P
Arthritis Rheum; 1997 Sep; 40(9):1636-43. PubMed ID: 9324018
[TBL] [Abstract][Full Text] [Related]
13. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
14. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
[TBL] [Abstract][Full Text] [Related]
15. Aflatoxin and p53 abnormality in duck hepatocellular carcinoma.
Imazeki F; Yokosuka O; Ohto M; Omata M
J Gastroenterol Hepatol; 1995; 10(6):646-9. PubMed ID: 8580407
[TBL] [Abstract][Full Text] [Related]
16. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
[TBL] [Abstract][Full Text] [Related]
17. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine neoplasms of the lung are not associated with point mutations at codon 12 of the Ki-ras gene.
Wagner SN; Müller R; Boehm J; Pütz B; Wünsch PH; Höfler H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 63(5):325-9. PubMed ID: 8100102
[TBL] [Abstract][Full Text] [Related]
19. Beta-catenin mutations and expression, 249serine p53 tumor suppressor gene mutation, and hepatitis B virus infection in southern African Blacks with hepatocellular carcinoma.
Elmileik H; Paterson AC; Kew MC
J Surg Oncol; 2005 Sep; 91(4):258-63. PubMed ID: 16121349
[TBL] [Abstract][Full Text] [Related]
20. Low frequency of H-ras activation in naturally occurring hepatocellular tumors of C3H/HeNCr mice.
Enomoto T; Weghorst CM; Ward JM; Anderson LM; Perantoni AO; Rice JM
Carcinogenesis; 1993 Sep; 14(9):1939-44. PubMed ID: 8403222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
